COMMUNIQUÉS West-GlobeNewswire

Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent
28/11/2017
RANCHO CORDOVA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing today announced that on November 21, 2017, the U.S. Patent and Trademark [...]
Aptevo Therapeutics Announces Plans to Conduct Phase 2 Study of Otlertuzumab in Peripheral T-Cell Lymphoma
28/11/2017
Anticipates 2 IND Filings in 2018 for Novel Bispecific Antibody Candidates SEATTLE, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel [...]
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2017
28/11/2017
CARLSBAD, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) announces financial results for the three and nine months ended September 30, 2017. To our [...]
Deciphera Pharmaceuticals, Inc. Announces Orphan Drug Designation from the EMA for DCC-2618 for the Treatment of Gastrointestinal Stromal Tumors
28/11/2017
WALTHAM, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH ) a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced [...]
G1 Therapeutics and AstraZeneca Enter Clinical Trial Collaboration in Non-Small Cell Lung Cancer
28/11/2017
RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ: GTHX ), a clinical-stage oncology company, today announced a clinical trial collaboration with AstraZeneca to evaluate [...]
Axsome Therapeutics Announces AXS-07 for the Treatment of Migraine
28/11/2017
Incorporates new molecular entity for migraine and Axsome’s MoSEIC™ technology Potential for superior efficacy as compared to current treatments FDA Pre-IND meeting written guidance received Issued U.S. patent provides [...]
ALK to launch updated corporate strategy on 4 December
28/11/2017
Copenhagen, 2017-11-28 12:50 CET (GLOBE NEWSWIRE) -- On Monday, 4 December 2017, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) will present its updated corporate strategy. That day at 11.00 a.m. (CET), ALK will host a [...]
ReWalk Robotics Announces Full Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares in Follow-on Public Offering
28/11/2017
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK ) (“ ReWalk ” or the “ Company ”) today announced that National Securities Corporation (“ National ”), [...]
Auris Medical Reports Third Quarter 2017 Financial Results and Provides Business Update
28/11/2017
HEALOS trial with AM-111 did not meet the primary efficacy endpoint, but showed statistically and clinically significant effect in profound acute hearing loss subpopulation Phase 3 results from Keyzilen ® TACTT3 trial [...]
Auris Medical Reports Top-Line Results from Phase 3 Trial of AM-111 in Sudden Deafness
28/11/2017
HEALOS trial did not meet primary efficacy endpoint in overall study population Clinically and statistically significant improvement in subpopulation of patients with profound acute hearing loss Conference call [...]
Cytovance Biologics, Inc. announces Bexion Pharmaceuticals Inc. has chosen Cytovance to manufacture the protein component and active ingredient of Bexion’s first clinical compound, BXQ-350
28/11/2017
OKLAHOMA CITY, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cytovance Biologics, Inc. (Cytovance), a leading full-service contract development and manufacturer of mammalian and microbial biologics, today announced that it has been [...]
US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert
28/11/2017
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ), (“Veritas” or the “Company”) announces its research arm, Cannevert Therapeutics Ltd. (“CTL”) [...]
Cannabis Wheaton Income Corp. Announces Proposed Shares for Debt Settlement
28/11/2017
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") has entered into settlement agreements (the " [...]
Prima BioMed Becomes Immutep
28/11/2017
SYDNEY, Australia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- We refer to shareholder approval granted at the Company’s Annual General Meeting held on 17 November 2017 to change the name of the Company from ‘Prima BioMed Ltd’ to [...]
REVA to Present at 29th Annual Piper Jaffray Healthcare Conference
28/11/2017
SAN DIEGO, Nov. 27, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that its Chief Executive Officer, Ms. Reggie Groves, is scheduled to present at the 29th Annual [...]
Accelerate Diagnostics Joins Sepsis Alliance in Global #GivingTuesday Movement to Raise Awareness of Sepsis as Medical Emergency
28/11/2017
TUCSON, Ariz., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. has teamed up with Sepsis Alliance for #GivingTuesday, November 28 th , a global day of giving that harnesses the collective power of [...]
AIT Therapeutics Announces Positive Preliminary Data for the Primary Endpoint of Safety in Its NO-NTM Abscessus Phase 2 Clinical Trial in Nontuberculous Mycobacteria (NTM) Patients
27/11/2017
No Serious Adverse Events Related to Treatment with Nitric Oxide Reported Compelling Preliminary Data on Key Secondary Endpoint of 6-Minute Walk NEW YORK, Nov. 27, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC: [...]
Aeterna Zentaris’ Marketing Authorization Application for Macrilen™ (macimorelin) for Evaluation of Adult Growth Hormone Deficiency Accepted by European Medicines Agency
27/11/2017
CHARLESTON, S.C., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) announced that the Marketing Authorization Application (“MAA”) for the use of Macrilen™ (macimorelin) for the [...]
Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27/11/2017
WALTHAM, Mass., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS ) today announced that its Board of Directors granted Joseph Kelly, in connection with his appointment as [...]

Pages